Top

Published in:

01-10-2016 | Review

Cardiac surgery 2015 reviewed

Authors: Torsten Doenst, Constanze Strüning, Alexandros Moschovas, David Gonzalez-Lopez, Yasin Essa, Hristo Kirov, Mahmoud Diab, Gloria Faerber

Published in: Clinical Research in Cardiology | Issue 10/2016

Abstract

For the year 2015, almost 19,000 published references can be found in PubMed when entering the search term “cardiac surgery”. The last year has been again characterized by lively discussions in the fields where classic cardiac surgery and modern interventional techniques overlap. Lacking evidence in the field of coronary revascularization with either percutaneous coronary intervention or bypass surgery has been added. As in the years before, CABG remains the gold standard for the revascularization of complex stable triple-vessel disease. Plenty of new information has been presented comparing the conventional to transcatheter aortic valve implantation (TAVI) demonstrating similar short- and mid-term outcomes at high and low risk, but even a survival advantage with transfemoral TAVI at intermediate risk. In addition, there were many relevant and interesting other contributions from the purely operative arena. This review article will summarize the most pertinent publications in the fields of coronary revascularization, surgical treatment of valve disease, heart failure (i.e., transplantation and ventricular assist devices), and aortic surgery. While the article does not have the expectation of being complete and cannot be free of individual interpretation, it provides a condensed summary that is intended to give the reader “solid ground” for up-to-date decision-making in cardiac surgery.

Jang WJ, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, Kim WS, Lee YT, Gwon HC (2015) Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation. JACC Cardiovasc Interv 8(2):271–279. doi:10.1016/j.jcin.2014.10.010 CrossRefPubMed

Stergiopoulos K, Boden WE, Hartigan P, Mobius-Winkler S, Hambrecht R, Hueb W, Hardison RM, Abbott JD, Brown DL (2014) Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med 174(2):232–240. doi:10.1001/jamainternmed.2013.12855 CrossRefPubMed

Iqbal J, Zhang YJ, Holmes DR, Morice MC, Mack MJ, Kappetein AP, Feldman T, Stahle E, Escaned J, Banning AP, Gunn JP, Colombo A, Steyerberg EW, Mohr FW, Serruys PW (2015) Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up. Circulation 131(14):1269–1277. doi:10.1161/CIRCULATIONAHA.114.013042 CrossRefPubMed

Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Choo SJ, Chung CH, Lee JW, Cohen DJ, Yeung AC, Hur SH, Seung KB, Ahn TH, Kwon HM, Lim DS, Rha SW, Jeong MH, Lee BK, Tresukosol D, Fu GS, Ong TK, Investigators BT (2015) Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med 372(13):1204–1212. doi:10.1056/NEJMoa1415447 CrossRefPubMed

Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL (2015) Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med 372(13):1213–1222. doi:10.1056/NEJMoa1412168 CrossRefPubMed

Habib RH, Dimitrova KR, Badour SA, Yammine MB, El-Hage-Sleiman AK, Hoffman DM, Geller CM, Schwann TA, Tranbaugh RF (2015) CABG versus PCI: greater benefit in long-term outcomes with multiple arterial bypass grafting. J Am Coll Cardiol 66(13):1417–1427. doi:10.1016/j.jacc.2015.07.060 CrossRefPubMed

Kikuchi K, Une D, Kurata A, Ruel M (2015) Off-pump minimally invasive coronary artery bypass grafting using the bilateral internal thoracic arteries and the right gastroepiproic artery. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezv281 PubMed

Blazek S, Rossbach C, Borger MA, Fuernau G, Desch S, Eitel I, Stiermaier T, Lurz P, Holzhey D, Schuler G, Mohr FW, Thiele H (2015) Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial. JACC Cardiovasc Interv 8(1 Pt A):30–38. doi:10.1016/j.jcin.2014.08.006 CrossRefPubMed

Deppe AC, Liakopoulos OJ, Kuhn EW, Slottosch I, Scherner M, Choi YH, Rahmanian PB, Wahlers T (2015) Minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for single-vessel disease: a meta-analysis of 2885 patients. Eur J Cardiothorac Surg 47(3):397–406. doi:10.1093/ejcts/ezu285 (discussion 406) CrossRefPubMed

10.

Harskamp RE, Vassiliades TA, Mehta RH, de Winter RJ, Lopes RD, Xian Y, Peterson ED, Puskas JD, Halkos ME (2015) Comparative effectiveness of hybrid coronary revascularization vs coronary artery bypass grafting. J Am Coll Surg 221(2):326 e321–334 e321. doi:10.1016/j.jamcollsurg.2015.03.012 CrossRef

11.

Raja SG, Benedetto U, Alkizwini E, Gupta S, Amrani M, Harefield Cardiac Outcomes Research G (2015) Propensity score adjusted comparison of MIDCAB versus full sternotomy left anterior descending artery revascularization. Innovations 10(3):174–178. doi:10.1097/IMI.0000000000000162 PubMed

12.

Rosenblum JM, Harskamp RE, Hoedemaker N, Walker P, Liberman HA, de Winter RJ, Vassiliades TA, Puskas JD, Halkos ME (2015) Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts. J Thorac Cardiovasc Surg. doi:10.1016/j.jtcvs.2015.10.061 PubMed

13.

Tatoulis J, Wynne R, Skillington PD, Buxton BF (2015) Total arterial revascularization: achievable and prognostically effective—a multicenter analysis. Ann Thorac Surg 100(4):1268–1275. doi:10.1016/j.athoracsur.2015.03.107 CrossRefPubMed

14.

Kurlansky PA, Traad EA, Dorman MJ, Galbut DL, Ebra G (2015) Bilateral versus single internal mammary artery grafting in the elderly: long-term survival benefit. Ann Thorac Surg 100(4):1374–1382. doi:10.1016/j.athoracsur.2015.04.019 CrossRefPubMed

15.

Gaudino M, Crea F, Cammertoni F, Massetti M (2015) The radial artery: a forgotten conduit. Ann Thorac Surg 99(4):1479–1485. doi:10.1016/j.athoracsur.2014.11.045 CrossRefPubMed

16.

Samano N, Geijer H, Liden M, Fremes S, Bodin L, Souza D (2015) The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: a randomized trial. J Thorac Cardiovasc Surg 150(4):880–888. doi:10.1016/j.jtcvs.2015.07.027 CrossRefPubMed

17.

Kowalewski M, Pawliszak W, Malvindi PG, Bokszanski MP, Perlinski D, Raffa GM, Kowalkowska ME, Zaborowska K, Navarese EP, Kolodziejczak M, Kowalewski J, Tarelli G, Taggart DP, Anisimowicz L (2016) Off-pump coronary artery bypass grafting improves short-term outcomes in high-risk patients compared with on-pump coronary artery bypass grafting: meta-analysis. J Thorac Cardiovasc Surg 151(1):60 e58–77 e58. doi:10.1016/j.jtcvs.2015.08.042 CrossRef

18.

Altarabsheh SE, Deo SV, Rababa’h AM, Lim JY, Cho YH, Sharma V, Jung SH, Shin E, Markowitz AH, Park SJ (2015) Off-pump coronary artery bypass reduces early stroke in octogenarians: a meta-analysis of 18,000 patients. Ann Thorac Surg 99(5):1568–1575. doi:10.1016/j.athoracsur.2014.12.057 CrossRefPubMed

19.

Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Stahle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW (2014) Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J 35(40):2821–2830. doi:10.1093/eurheartj/ehu213 CrossRefPubMed

20.

Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O’Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL, Investigators S (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 364(17):1607–1616. doi:10.1056/NEJMoa1100356 CrossRefPubMedPubMedCentral

21.

Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL, Investigators S (2016) Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med 374(16):1511–1520. doi:10.1056/NEJMoa1602001 CrossRefPubMed

22.

Bonow RO, Castelvecchio S, Panza JA, Berman DS, Velazquez EJ, Michler RE, She L, Holly TA, Desvigne-Nickens P, Kosevic D, Rajda M, Chrzanowski L, Deja M, Lee KL, White H, Oh JK, Doenst T, Hill JA, Rouleau JL, Menicanti L, Investigators ST (2015) Severity of remodeling, myocardial viability, and survival in ischemic LV dysfunction after surgical revascularization. JACC Cardiovasc Imaging 8(10):1121–1129. doi:10.1016/j.jcmg.2015.03.013 CrossRefPubMed

23.

MacDonald MR, She L, Doenst T, Binkley PF, Rouleau JL, Tan RS, Lee KL, Miller AB, Sopko G, Szalewska D, Waclawiw MA, Dabrowski R, Castelvecchio S, Adlbrecht C, Michler RE, Oh JK, Velazquez EJ, Petrie MC (2015) Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Eur J Heart Fail 17(7):725–734. doi:10.1002/ejhf.288 CrossRefPubMedPubMedCentral

24.

Jolicoeur EM, Dunning A, Castelvecchio S, Dabrowski R, Waclawiw MA, Petrie MC, Stewart R, Jhund PS, Desvigne-Nickens P, Panza JA, Bonow RO, Sun B, San TR, Al-Khalidi HR, Rouleau JL, Velazquez EJ, Cleland JG (2015) Importance of Angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH. J Am Coll Cardiol 66(19):2092–2100. doi:10.1016/j.jacc.2015.08.882 CrossRefPubMed

25.

Davierwala PM, Verevkin A, Leontyev S, Misfeld M, Borger MA, Mohr FW (2015) Does timing of coronary artery bypass surgery affect early and long-term outcomes in patients with non-ST-segment-elevation myocardial infarction? Circulation 132(8):731–740. doi:10.1161/CIRCULATIONAHA.115.015279 CrossRefPubMed

26.

Wu H, Wang J, Sun H, Lv B, Wang X, Hu X, Ma W, Zhang J (2015) Preoperative continuation of aspirin therapy may improve perioperative saphenous venous graft patency after off-pump coronary artery bypass grafting. Ann Thorac Surg 99(2):576–580. doi:10.1016/j.athoracsur.2014.07.074 CrossRefPubMed

27.

Tuzcu EM, Kapadia SR, Svensson LG (2015) Well-intended NOTION, ahead of practice. J Am Coll Cardiol 65(20):2195–2197. doi:10.1016/j.jacc.2015.03.560 CrossRefPubMed

28.

Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG, Investigators Pt (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2477–2484. doi:10.1016/S0140-6736(15)60308-7 CrossRefPubMed

29.

Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Lee JS, Hermiller JB Jr, Chetcuti S, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Qiao H, Popma JJ (2015) 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol 66(2):113–121. doi:10.1016/j.jacc.2015.05.017 CrossRefPubMed

30.

Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG, Investigators P (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620. doi:10.1056/NEJMoa1514616 CrossRefPubMed

31.

Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P, Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D’Agostino RB Jr, Leon MB (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. doi:10.1016/S0140-6736(16)30073-3 PubMed

32.

Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrom T, Clemmensen P, Hansen PB, Andersen LW, Olsen PS, Sondergaard L (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 65(20):2184–2194. doi:10.1016/j.jacc.2015.03.014 CrossRefPubMed

33.

Tamburino C, Barbanti M, D’Errigo P, Ranucci M, Onorati F, Covello RD, Santini F, Rosato S, Santoro G, Fusco D, Grossi C, Seccareccia F, Group OR (2015) 1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: results from the Italian OBSERVANT Study. J Am Coll Cardiol 66(7):804–812. doi:10.1016/j.jacc.2015.06.013 CrossRefPubMed

34.

Walther T, Hamm CW, Schuler G, Berkowitsch A, Kotting J, Mangner N, Mudra H, Beckmann A, Cremer J, Welz A, Lange R, Kuck KH, Mohr FW, Mollmann H, Board GE (2015) Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY Registry. J Am Coll Cardiol 65(20):2173–2180. doi:10.1016/j.jacc.2015.03.034 CrossRefPubMed

35.

Kuck KH, Eggebrecht H, Figulla HR, Haude M, Katus H, Moellmann H, Naber CK, Schunkert H, Thiele H, Hamm C (2015) Qualitaetskriterien zur Durchführung der transvaskulaeren Aortenklappenimplantation. Kardiologe 9:11–26. doi:10.1007/s12181-014-0622-8 CrossRef

36.

Dizon JM, Nazif TM, Hess PL, Biviano A, Garan H, Douglas PS, Kapadia S, Babaliaros V, Herrmann HC, Szeto WY, Jilaihawi H, Fearon WF, Tuzcu EM, Pichard AD, Makkar R, Williams M, Hahn RT, Xu K, Smith CR, Leon MB, Kodali SK, Office PP (2015) Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart 101(20):1665–1671. doi:10.1136/heartjnl-2015-307666 CrossRefPubMed

37.

David TE, Feindel CM, Bos J, Ivanov J, Armstrong S (2008) Aortic valve replacement with Toronto SPV bioprosthesis: optimal patient survival but suboptimal valve durability. J Thorac Cardiovasc Surg 135(1):19–24. doi:10.1016/j.jtcvs.2007.04.068 CrossRefPubMed

38.

Egbe AC, Connolly HM, Schaff HV (2016) Bioprosthetic valve thrombosis: what we know and what we need to know. J Thorac Cardiovasc Surg. doi:10.1016/j.jtcvs.2016.04.049 PubMed

39.

De Marchena E, Mesa J, Pomenti S, Marin YKC, Marincic X, Yahagi K, Ladich E, Kutz R, Aga Y, Ragosta M, Chawla A, Ring ME, Virmani R (2015) Thrombus formation following transcatheter aortic valve replacement. JACC Cardiovasc Interv 8(5):728–739. doi:10.1016/j.jcin.2015.03.005 CrossRefPubMed

40.

Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, de Backer O, Asch FM, Ruiz CE, Olsen NT, Trento A, Friedman J, Berman D, Cheng W, Kashif M, Jelnin V, Kliger CA, Guo H, Pichard AD, Weissman NJ, Kapadia S, Manasse E, Bhatt DL, Leon MB, Sondergaard L (2015) Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 373(21):2015–2024. doi:10.1056/NEJMoa1509233 CrossRefPubMed

41.

Doenst T, Amorim PA, Diab M, Hagendorff A, Faerber G, Graff J, Rastan A, Deutsch O, Eichinger W, Investigators PI (2014) Novel thoughts on patient-prosthesis mismatch in aortic valve replacement: the rationale for the PAR I trial. Thorac Cardiovasc Surg 62(6):463–468. doi:10.1055/s-0034-1377063 CrossRefPubMed

42.

Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V, Rihal CS, Zajarias A, Doshi D, Davidson M, Tuzcu EM, Stewart W, Weissman NJ, Svensson L, Greason K, Maniar H, Mack M, Anwaruddin S, Leon MB, Hahn RT (2015) Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J 36(7):449–456. doi:10.1093/eurheartj/ehu384 CrossRefPubMed

43.

Kodali S (2015) Clinical and echocardiographic outcomes at 30 days with the SAPIEN 3 TAVR system in inoperable, high-risk and intermediate-risk AS patients. Paper presented at the ACC Scientific Sessions, San Diego

44.

Wendt D, Al-Rashid F, Kahlert P, Eissmann M, El-Chilali K, Janosi RA, Pasa S, Tsagakis K, Liakopoulos O, Erbel R, Jakob H, Thielmann M (2015) Low incidence of paravalvular leakage with the balloon-expandable Sapien 3 Transcatheter Heart Valve. Ann Thorac Surg 100(3):819–825. doi:10.1016/j.athoracsur.2015.03.079 (discussion 825–816) CrossRefPubMed

45.

Oh JK, Little SH, Abdelmoneim SS, Reardon MJ, Kleiman NS, Lin G, Bach D, Gillam L, Kar B, Coselli J, Sengupta PP, Grewal K, Chang J, Chang Y, Boulware M, Adams DH, Popma JJ, CoreValve USPTCI (2015) Regression of paravalvular aortic regurgitation and remodeling of self-expanding transcatheter aortic valve: an observation from the CoreValve U.S. Pivotal Trial. JACC Cardiovasc Imaging 8(12):1364–1375. doi:10.1016/j.jcmg.2015.07.012 CrossRefPubMed

46.

Blackstone EH, Suri RM, Rajeswaran J, Babaliaros V, Douglas PS, Fearon WF, Miller DC, Hahn RT, Kapadia S, Kirtane AJ, Kodali SK, Mack M, Szeto WY, Thourani VH, Tuzcu EM, Williams MR, Akin JJ, Leon MB, Svensson LG (2015) Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation 131(22):1989–2000. doi:10.1161/CIRCULATIONAHA.114.012525 CrossRefPubMed

47.

Merk DR, Lehmann S, Holzhey DM, Dohmen P, Candolfi P, Misfeld M, Mohr FW, Borger MA (2015) Minimal invasive aortic valve replacement surgery is associated with improved survival: a propensity-matched comparison. Eur J Cardiothorac Surg 47(1):11–17. doi:10.1093/ejcts/ezu068 (discussion 17) CrossRefPubMed

48.

Ghanta RK, Lapar DJ, Kern JA, Kron IL, Speir AM, Fonner E Jr, Quader M, Ailawadi G (2015) Minimally invasive aortic valve replacement provides equivalent outcomes at reduced cost compared with conventional aortic valve replacement: a real-world multi-institutional analysis. J Thorac Cardiovasc Surg 149(4):1060–1065. doi:10.1016/j.jtcvs.2015.01.014 CrossRefPubMedPubMedCentral

49.

Bowdish ME, Hui DS, Cleveland JD, Mack WJ, Sinha R, Ranjan R, Cohen RG, Baker CJ, Cunningham MJ, Barr ML, Starnes VA (2015) A comparison of aortic valve replacement via an anterior right minithoracotomy with standard sternotomy: a propensity score analysis of 492 patientsdagger. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezv038 PubMed

50.

Miceli A, Gilmanov D, Murzi M, Marchi F, Ferrarini M, Cerillo AG, Quaini E, Solinas M, Berti S, Glauber M (2015) Minimally invasive aortic valve replacement with a sutureless valve through a right anterior mini-thoracotomy versus transcatheter aortic valve implantation in high-risk patients. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezv210

51.

Muneretto C, Alfieri O, Cesana BM, Bisleri G, De Bonis M, Di Bartolomeo R, Savini C, Folesani G, Di Bacco L, Rambaldini M, Maureira JP, Laborde F, Tespili M, Repossini A, Folliguet T (2015) A comparison of conventional surgery, transcatheter aortic valve replacement, and sutureless valves in “real-world” patients with aortic stenosis and intermediate- to high-risk profile. J Thorac Cardiovasc Surg 150(6):1570–1579. doi:10.1016/j.jtcvs.2015.08.052 CrossRefPubMed

52.

Colli A, Marchetto G, Salizzoni S, Rinaldi M, Di Marco L, Pacini D, Di Bartolomeo R, Nicolini F, Gherli T, Agrifoglio M, Borghetti V, Khoury G, De Paolis M, Zoffoli G, Mangino D, Amorim MJ, Manzan E, Zucchetta F, Balduzzi S, Gerosa G (2015) The TRIBECA study: (TRI)fecta (B)ioprosthesis (E)valuation vs (C)arpentier Magna-Ease in (A)ortic positiondagger. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezv070

53.

Borger MA, Moustafine V, Conradi L, Knosalla C, Richter M, Merk DR, Doenst T, Hammerschmidt R, Treede H, Dohmen P, Strauch JT (2015) A randomized multicenter trial of minimally invasive rapid deployment versus conventional full sternotomy aortic valve replacement. Ann Thorac Surg 99(1):17–25. doi:10.1016/j.athoracsur.2014.09.022 CrossRefPubMed

54.

Laborde F, Fischlein T, Hakim-Meibodi K, Misfeld M, Carrel T, Zembala M, Madonna F, Meuris B, Haverich A, Shrestha M, Cavalier Trial I (2015) Clinical and haemodynamic outcomes in 658 patients receiving the perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier Trial). Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezv257

55.

Theron A, Gariboldi V, Grisoli D, Jaussaud N, Morera P, Lagier D, Leroux S, Amanatiou C, Guidon C, Riberi A, Collart F (2015) Rapid deployment of aortic bioprosthesis in elderly patients with small aortic annulus. Ann Thorac Surg. doi:10.1016/j.athoracsur.2015.09.024 PubMed

56.

Doenst T, Struning C, Moschovas A, Gonzalez-Lopez D, Valchanov I, Kirov H, Diab M, Faerber G (2015) Cardiac surgery 2014 reviewed. Clin Res Cardiol 104(12):1006–1020. doi:10.1007/s00392-015-0914-4 CrossRefPubMed

57.

Authors/Task Force M, Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, Document R, Erol C, Nihoyannopoulos P, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, Halvorsen S, Hoen B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GY, Mestres CA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, Tamargo J, Walker DM (2015) 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36(44):3075–3128. doi:10.1093/eurheartj/ehv319 CrossRef

58.

Beckmann A, Funkat AK, Lewandowski J, Frie M, Ernst M, Hekmat K, Schiller W, Gummert JF, Cremer JT (2015) Cardiac surgery in Germany during 2014: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. doi:10.1055/s-0035-1565257

59.

Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC (1991) Twelve-year comparison of a Bjork–Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med 324(9):573–579. doi:10.1056/NEJM199102283240901 CrossRefPubMed

60.

Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH (2000) Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 36(4):1152–1158CrossRefPubMed

61.

Glaser N, Jackson V, Holzmann MJ, Franco-Cereceda A, Sartipy U (2015) Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50–69 years. Eur Heart J. doi:10.1093/eurheartj/ehv580 PubMed

62.

Koertke H, Zittermann A, Wagner O, Secer S, Christ of H, Sciangula A, Saggau W, Sack FU, Ennker J, Cremer J, Musumeci F, Gummert JF (2015) Telemedicine-guided, very low-dose international normalized ratio self-control in patients with mechanical heart valve implants. Eur Heart J 36(21):1297–1305. doi:10.1093/eurheartj/ehu330 CrossRefPubMed

63.

Goldstone AB, Patrick WL, Cohen JE, Aribeana CN, Popat R, Woo YJ (2015) Early surgical intervention or watchful waiting for the management of asymptomatic mitral regurgitation: a systematic review and meta-analysis. Ann Cardiothorac Surg 4(3):220–229. doi:10.3978/j.issn.2225-319X.2015.04.01 PubMedPubMedCentral

64.

Yazdchi F, Koch CG, Mihaljevic T, Hachamovitch R, Lowry AM, He J, Gillinov AM, Blackstone EH, Sabik JF 3rd (2015) Increasing disadvantage of “Watchful Waiting” for repairing degenerative mitral valve disease. Ann Thorac Surg 99(6):1992–2000. doi:10.1016/j.athoracsur.2015.01.065 CrossRefPubMed

65.

Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, Hung JW, Voisine P, Dagenais F, Gillinov AM, Thourani V, Argenziano M, Gammie JS, Mack M, Demers P, Atluri P, Rose EA, O’Sullivan K, Williams DL, Bagiella E, Michler RE, Weisel RD, Miller MA, Geller NL, Taddei-Peters WC, Smith PK, Moquete E, Overbey JR, Kron IL, O’Gara PT, Acker MA, Ctsn (2015) Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. doi:10.1056/NEJMoa1512913

66.

Kron IL, Hung J, Overbey JR, Bouchard D, Gelijns AC, Moskowitz AJ, Voisine P, O’Gara PT, Argenziano M, Michler RE, Gillinov M, Puskas JD, Gammie JS, Mack MJ, Smith PK, Sai-Sudhakar C, Gardner TJ, Ailawadi G, Zeng X, O’Sullivan K, Parides MK, Swayze R, Thourani V, Rose EA, Perrault LP, Acker MA, Investigators C (2015) Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg 149(3):752 e751–761 e751. doi:10.1016/j.jtcvs.2014.10.120 CrossRef

67.

Samad Z, Shaw LK, Phelan M, Ersboll M, Risum N, Al-Khalidi HR, Glower DD, Milano CA, Alexander JH, O’Connor CM, Wang A, Velazquez EJ (2015) Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunction. Eur Heart J 36(40):2733–2741. doi:10.1093/eurheartj/ehv343 CrossRefPubMed

68.

Puls M, Lubos E, Boekstegers P, von Bardeleben RS, Ouarrak T, Butter C, Zuern CS, Bekeredjian R, Sievert H, Nickenig G, Eggebrecht H, Senges J, Schillinger W (2015) One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J. doi:10.1093/eurheartj/ehv627 PubMedPubMedCentral

69.

Downs EA, Lim DS, Saji M, Ailawadi G (2015) Current state of transcatheter mitral valve repair with the MitraClip. Ann Cardiothorac Surg 4(4):335–340. doi:10.3978/j.issn.2225-319X.2015.02.02 PubMedPubMedCentral

70.

Adamo M, Barbanti M, Curello S, Fiorina C, Chiari E, Chizzola G, Capodanno D, Tamburino C, Metra M, Ettori F (2015) Effectiveness of MitraClip therapy in patients with refractory heart failure. J Interv Cardiol 28(1):61–68. doi:10.1111/joic.12179 CrossRefPubMed

71.

Ansari MT, Ahmadzai N, Coyle K, Coyle D, Moher D (2015) Mitral valve clip for treatment of mitral regurgitation: an evidence-based analysis. Ont Health Technol Assess Ser 15(12):1–104PubMedPubMedCentral

72.

Velazquez EJ, Samad Z, Al-Khalidi HR, Sangli C, Grayburn PA, Massaro JM, Stevens SR, Feldman TE, Krucoff MW (2015) The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison. Am Heart J 170(5):1050 e1053–1059 e1053. doi:10.1016/j.ahj.2015.08.004 CrossRef

73.

Chikwe J, Itagaki S, Anyanwu A, Adams DH (2015) Impact of concomitant tricuspid annuloplasty on tricuspid regurgitation, right ventricular function, and pulmonary artery hypertension after repair of mitral valve prolapse. J Am Coll Cardiol 65(18):1931–1938. doi:10.1016/j.jacc.2015.01.059 CrossRefPubMed

74.

Moscarelli M, Fattouch K, Casula R, Speziale G, Lancellotti P, Athanasiou T (2015) What is the role of minimally invasive mitral valve surgery in high-risk patients? A meta-analysis of observational studies. Ann Thorac Surg. doi:10.1016/j.athoracsur.2015.08.050 PubMed

75.

Ad N, Holmes SD, Shuman DJ, Pritchard G, Massimiano PS (2015) Minimally invasive mitral valve surgery without aortic cross-clamping and with femoral cannulation is not associated with increased risk of stroke compared with traditional mitral valve surgery: a propensity score-matched analysis. Eur J Cardiothorac Surg 48(6):868–872. doi:10.1093/ejcts/ezv017 CrossRefPubMed

76.

Elefteriades JA, Ziganshin BA, Rizzo JA, Fang H, Tranquilli M, Paruchuri V, Kuzmik G, Gubernikoff G, Dumfarth J, Charilaou P, Theodoropoulos P (2015) Indications and imaging for aortic surgery: size and other matters. J Thorac Cardiovasc Surg 149(2 Suppl):S10–S13. doi:10.1016/j.jtcvs.2014.07.066 CrossRefPubMed

77.

Itagaki S, Chikwe JP, Chiang YP, Egorova NN, Adams DH (2015) Long-term risk for aortic complications after aortic valve replacement in patients with bicuspid aortic valve versus Marfan syndrome. J Am Coll Cardiol 65(22):2363–2369. doi:10.1016/j.jacc.2015.03.575 CrossRefPubMed

78.

Shrestha M, Bachet J, Bavaria J, Carrel TP, De Paulis R, Di Bartolomeo R, Etz CD, Grabenwoger M, Grimm M, Haverich A, Jakob H, Martens A, Mestres CA, Pacini D, Resch T, Schepens M, Urbanski PP, Czerny M (2015) Current status and recommendations for use of the frozen elephant trunk technique: a position paper by the Vascular Domain of EACTS. Eur J Cardiothorac Surg 47(5):759–769. doi:10.1093/ejcts/ezv085 CrossRefPubMed

79.

Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, Mancini D, Camacho M, Zucker M, Leprince P, Padera R, Kobashigawa J, Investigators PIt (2015) Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet 385(9987):2577–2584. doi:10.1016/S0140-6736(15)60261-6 CrossRefPubMed

80.

Tong MZ, Smedira NG, Soltesz EG, Starling RC, Koval CE, Porepa L, Moazami N (2015) Outcomes of heart transplant after left ventricular assist device specific and related infection. Ann Thorac Surg 100(4):1292–1297. doi:10.1016/j.athoracsur.2015.04.047 CrossRefPubMed

81.

Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, Miller MA, Baldwin JT, Young JB (2015) Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant 34(12):1495–1504. doi:10.1016/j.healun.2015.10.003 CrossRefPubMed

82.

Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selzman CH, Shah KB, Loebe M, Moazami N, Long JW, Stehlik J, Kasirajan V, Haas DC, O’Connell JB, Boyle AJ, Farrar DJ, Rogers JG, Investigators RS (2015) Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results From the ROADMAP Study. J Am Coll Cardiol 66(16):1747–1761. doi:10.1016/j.jacc.2015.07.075 CrossRefPubMed

83.

Netuka I, Sood P, Pya Y, Zimpfer D, Krabatsch T, Garbade J, Rao V, Morshuis M, Marasco S, Beyersdorf F, Damme L, Schmitto JD (2015) Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study. J Am Coll Cardiol 66(23):2579–2589. doi:10.1016/j.jacc.2015.09.083 CrossRefPubMed

Title: Cardiac surgery 2015 reviewed
Authors: Torsten Doenst
Constanze Strüning
Alexandros Moschovas
David Gonzalez-Lopez
Yasin Essa
Hristo Kirov
Mahmoud Diab
Gloria Faerber
Publication date: 01-10-2016
Publisher: Springer Berlin Heidelberg
Published in: Clinical Research in Cardiology / Issue 10/2016
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-016-1013-x

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2016

Epicardial ventricular tachycardia substrate visualized by magnetic resonance imaging: need for a transpericardial ablation approach?

Renal denervation for treatment of ventricular arrhythmias: data from an International Multicenter Registry

Diagnostic value of speckle-tracking echocardiography in confirmed cardiac sarcoidosis

Heart failure and the holidays